144 related articles for article (PubMed ID: 25403449)
1. Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma.
Stenman A; Svahn F; Welander J; Gustavson B; Söderkvist P; Gimm O; Juhlin CC
Endocr Pathol; 2015 Mar; 26(1):9-14. PubMed ID: 25403449
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.
Juhlin CC; Stenman A; Haglund F; Clark VE; Brown TC; Baranoski J; Bilguvar K; Goh G; Welander J; Svahn F; Rubinstein JC; Caramuta S; Yasuno K; Günel M; Bäckdahl M; Gimm O; Söderkvist P; Prasad ML; Korah R; Lifton RP; Carling T
Genes Chromosomes Cancer; 2015 Sep; 54(9):542-54. PubMed ID: 26032282
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease.
Kimura N; Watanabe T; Fukase M; Wakita A; Noshiro T; Kimura I
Mod Pathol; 2002 Mar; 15(3):183-8. PubMed ID: 11904334
[TBL] [Abstract][Full Text] [Related]
4. The NF1 gene: a frequent mutational target in sporadic pheochromocytomas and beyond.
Welander J; Söderkvist P; Gimm O
Endocr Relat Cancer; 2013 Aug; 20(4):C13-7. PubMed ID: 23756430
[TBL] [Abstract][Full Text] [Related]
5. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
[TBL] [Abstract][Full Text] [Related]
6. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
Stenman A; Zedenius J; Juhlin CC
Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
[TBL] [Abstract][Full Text] [Related]
7. Absence of the BRAF V600E mutation in pheochromocytoma.
Paulsson JO; Svahn F; Welander J; Brunaud L; Söderkvist P; Gimm O; Stenman A; Juhlin CC
J Endocrinol Invest; 2016 Jun; 39(6):715-6. PubMed ID: 26710756
[TBL] [Abstract][Full Text] [Related]
8. Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma.
Welander J; Andreasson A; Brauckhoff M; Bäckdahl M; Larsson C; Gimm O; Söderkvist P
Endocr Relat Cancer; 2014 Jun; 21(3):495-504. PubMed ID: 24741025
[TBL] [Abstract][Full Text] [Related]
9. Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas.
Welander J; Larsson C; Bäckdahl M; Hareni N; Sivlér T; Brauckhoff M; Söderkvist P; Gimm O
Hum Mol Genet; 2012 Dec; 21(26):5406-16. PubMed ID: 23010473
[TBL] [Abstract][Full Text] [Related]
10. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
Opocher G; Conton P; Schiavi F; Macino B; Mantero F
Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
[TBL] [Abstract][Full Text] [Related]
11. ATRX driver mutation in a composite malignant pheochromocytoma.
Comino-Méndez I; Tejera ÁM; Currás-Freixes M; Remacha L; Gonzalvo P; Tonda R; Letón R; Blasco MA; Robledo M; Cascón A
Cancer Genet; 2016 Jun; 209(6):272-7. PubMed ID: 27209355
[TBL] [Abstract][Full Text] [Related]
12. Domain landscapes of somatic NF1 mutations in pheochromocytoma and paraganglioma.
Tabebi M; Frikha F; Volpe M; Gimm O; Söderkvist P
Gene; 2023 Jul; 872():147432. PubMed ID: 37062455
[TBL] [Abstract][Full Text] [Related]
13. Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma.
Burnichon N; Buffet A; Parfait B; Letouzé E; Laurendeau I; Loriot C; Pasmant E; Abermil N; Valeyrie-Allanore L; Bertherat J; Amar L; Vidaud D; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2012 Dec; 21(26):5397-405. PubMed ID: 22962301
[TBL] [Abstract][Full Text] [Related]
14.
Evenepoel L; Helaers R; Vroonen L; Aydin S; Hamoir M; Maiter D; Vikkula M; Persu A
Endocr Relat Cancer; 2017 Aug; 24(8):L57-L61. PubMed ID: 28515046
[No Abstract] [Full Text] [Related]
15. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.
Bausch B; Borozdin W; Mautner VF; Hoffmann MM; Boehm D; Robledo M; Cascon A; Harenberg T; Schiavi F; Pawlu C; Peczkowska M; Letizia C; Calvieri S; Arnaldi G; Klingenberg-Noftz RD; Reisch N; Fassina A; Brunaud L; Walter MA; Mannelli M; MacGregor G; Palazzo FF; Barontini M; Walz MK; Kremens B; Brabant G; Pfäffle R; Koschker AC; Lohoefner F; Mohaupt M; Gimm O; Jarzab B; McWhinney SR; Opocher G; Januszewicz A; Kohlhase J; Eng C; Neumann HP;
J Clin Endocrinol Metab; 2007 Jul; 92(7):2784-92. PubMed ID: 17426081
[TBL] [Abstract][Full Text] [Related]
16. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
[TBL] [Abstract][Full Text] [Related]
17. The occurrence of SDHB gene mutations in pheochromocytoma.
Van Nederveen FH; Dinjens WN; Korpershoek E; De Krijger RR
Ann N Y Acad Sci; 2006 Aug; 1073():177-82. PubMed ID: 17102084
[TBL] [Abstract][Full Text] [Related]
18. Loss of the neurofibromin-NF1 gene product and composite pheochromocytoma.
Kimura N; Fukase M; Wakita A; Kimura I
Ann N Y Acad Sci; 2002 Oct; 971():536-8. PubMed ID: 12438177
[No Abstract] [Full Text] [Related]
19. Activating FGFR1 Mutations in Sporadic Pheochromocytomas.
Welander J; Łysiak M; Brauckhoff M; Brunaud L; Söderkvist P; Gimm O
World J Surg; 2018 Feb; 42(2):482-489. PubMed ID: 29159601
[TBL] [Abstract][Full Text] [Related]
20. H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.
Oudijk L; de Krijger RR; Rapa I; Beuschlein F; de Cubas AA; Dei Tos AP; Dinjens WN; Korpershoek E; Mancikova V; Mannelli M; Papotti M; Vatrano S; Robledo M; Volante M
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1376-80. PubMed ID: 24684458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
